论文部分内容阅读
Phencyclidine (PCP), an open channel antagonist of the NMDA subtype of glutamate receptor, induces schizophrenia-like behavior in humans and animals and increases glutamate and dopamine release in the medial prefrontal cortex and nucleus accumbens, brain regions associated with psychosis.